0001209191-18-003981.txt : 20180117
0001209191-18-003981.hdr.sgml : 20180117
20180117164530
ACCESSION NUMBER: 0001209191-18-003981
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180116
FILED AS OF DATE: 20180117
DATE AS OF CHANGE: 20180117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEIDEN JEFFREY M
CENTRAL INDEX KEY: 0001242825
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 18531895
MAIL ADDRESS:
STREET 1: 40 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-16
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001242825
LEIDEN JEFFREY M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
1
0
0
CEO & President
Common Stock
2018-01-16
4
M
0
44250
48.74
A
176747
D
Common Stock
2018-01-16
4
M
0
55313
45.11
A
232060
D
Common Stock
2018-01-16
4
S
0
42371
155.77
D
189689
D
Common Stock
2018-01-16
4
S
0
19808
156.62
D
169881
D
Common Stock
2018-01-16
4
S
0
11471
157.67
D
158410
D
Common Stock
2018-01-16
4
S
0
17918
158.79
D
140492
D
Common Stock
2018-01-16
4
S
0
7995
159.39
D
132497
D
Common Stock
440
I
401(k)
Stock Option (Right to Buy)
48.74
2018-01-16
4
M
0
44250
0.00
D
2022-07-24
Common Stock
44250
0
D
Stock Option (Right to Buy)
45.11
2018-01-16
4
M
0
55313
0.00
D
2023-02-04
Common Stock
55313
0
D
Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $155.77 (range $155.18 to $156.17).
Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $156.62 (range $156.18 to $157.17).
Open market sales reported on this line occurred at a weighted average price of $157.67 (range $157.18 to $158.17).
Open market sales reported on this line occurred at a weighted average price of $158.79 (range $158.18 to $159.16).
Open market sales reported on this line occurred at a weighted average price of $159.39 (range $159.18 to $159.75).
Fully vested.
/s/ Omar White, Attorney-in-Fact
2018-01-17